Cargando…

Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics

This cross-sectional study assesses pharmacy participation in the 340B Drug Pricing Program following the 2010 expansion and the extent to which growth has occurred in socioeconomically disadvantaged neighborhoods.

Detalles Bibliográficos
Autores principales: Lin, John K., Li, Pengxiang, Doshi, Jalpa A., Desai, Sunita M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206190/
https://www.ncbi.nlm.nih.gov/pubmed/35977245
http://dx.doi.org/10.1001/jamahealthforum.2022.1435
_version_ 1784729284665933824
author Lin, John K.
Li, Pengxiang
Doshi, Jalpa A.
Desai, Sunita M.
author_facet Lin, John K.
Li, Pengxiang
Doshi, Jalpa A.
Desai, Sunita M.
author_sort Lin, John K.
collection PubMed
description This cross-sectional study assesses pharmacy participation in the 340B Drug Pricing Program following the 2010 expansion and the extent to which growth has occurred in socioeconomically disadvantaged neighborhoods.
format Online
Article
Text
id pubmed-9206190
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-92061902022-07-05 Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics Lin, John K. Li, Pengxiang Doshi, Jalpa A. Desai, Sunita M. JAMA Health Forum Research Letter This cross-sectional study assesses pharmacy participation in the 340B Drug Pricing Program following the 2010 expansion and the extent to which growth has occurred in socioeconomically disadvantaged neighborhoods. American Medical Association 2022-06-17 /pmc/articles/PMC9206190/ /pubmed/35977245 http://dx.doi.org/10.1001/jamahealthforum.2022.1435 Text en Copyright 2022 Lin JK et al. JAMA Health Forum. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Lin, John K.
Li, Pengxiang
Doshi, Jalpa A.
Desai, Sunita M.
Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics
title Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics
title_full Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics
title_fullStr Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics
title_full_unstemmed Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics
title_short Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics
title_sort assessment of us pharmacies contracted with health care institutions under the 340b drug pricing program by neighborhood socioeconomic characteristics
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206190/
https://www.ncbi.nlm.nih.gov/pubmed/35977245
http://dx.doi.org/10.1001/jamahealthforum.2022.1435
work_keys_str_mv AT linjohnk assessmentofuspharmaciescontractedwithhealthcareinstitutionsunderthe340bdrugpricingprogrambyneighborhoodsocioeconomiccharacteristics
AT lipengxiang assessmentofuspharmaciescontractedwithhealthcareinstitutionsunderthe340bdrugpricingprogrambyneighborhoodsocioeconomiccharacteristics
AT doshijalpaa assessmentofuspharmaciescontractedwithhealthcareinstitutionsunderthe340bdrugpricingprogrambyneighborhoodsocioeconomiccharacteristics
AT desaisunitam assessmentofuspharmaciescontractedwithhealthcareinstitutionsunderthe340bdrugpricingprogrambyneighborhoodsocioeconomiccharacteristics